Sensei Biotherapeutics's market cap is currently ―. The company's EPS TTM is $-1.212; its P/E ratio is -0.81; Sensei Biotherapeutics is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	$ 55.00K	-	$ 0.00
Gross Profit	-	-	$ 55.00K	-	-
EBIT	$ 545.00K	$ 220.00K	$ -11.10M	$ -13.05M	$ -13.41M
EBITDA	$ 1.20M	$ 905.00K	$ -10.43M	$ -12.39M	$ -13.06M
Net Income Common Stockholders	$ -7.12M	$ -9.39M	$ -10.18M	$ -12.23M	$ -13.42M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 72.01M	$ 78.84M	$ 95.50M	$ 107.12M	$ 116.56M
Total Assets	$ 81.66M	$ 89.58M	$ 107.93M	$ 118.38M	$ 128.80M
Total Debt	$ 6.77M	$ 7.26M	$ 7.75M	$ 8.03M	$ 8.40M
Net Debt	$ -65.24M	$ -71.58M	$ -87.75M	$ -99.08M	$ -108.16M
Total Liabilities	$ 10.66M	$ 10.38M	$ 13.08M	$ 14.97M	$ 14.82M
Stockholders Equity	$ 71.00M	$ 79.20M	$ 94.85M	$ 103.41M	$ 113.99M
Cash Flow	-
Free Cash Flow	$ -4.66M	$ -9.34M	$ -11.88M	$ -9.57M	$ -7.05M
Operating Cash Flow	$ -4.66M	$ -9.46M	$ -11.74M	$ -9.57M	$ -6.80M
Investing Cash Flow	$ 8.31M	$ 19.53M	$ 2.31M	$ 16.04M	$ 8.52M
Financing Cash Flow	$ -2.53M	$ -7.95M	$ -262.00K	$ -124.00K	$ -163.00K

Currency in USD

Sensei Biotherapeutics Earnings and Revenue History

Income Statement >

Sensei Biotherapeutics Debt to Assets

Balance Sheet >

Sensei Biotherapeutics Cash Flow

Cash Flow >

Sensei Biotherapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing